Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31060098 | 1.00 | NR4A1 (0.53) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL10390869 | 0.84 | AKR1B10 (0.56) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL18652132 | 0.83 | NR4A1 (0.52) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL15849622 | 0.82 | NR4A1 (0.50) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL10391314 | 0.81 | HPGD (0.50) | PIN1TDP1MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL6927453 | 0.80 | NR4A1 (0.49) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL18650130 | 0.79 | NR4A1 (0.47) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL9716639 | 0.79 | NR4A1 (0.51) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL10407111 | 0.79 | NR4A1 (0.59) | NR4A1NR4A2NR4A3PTPN1CDC25B | |
| SCHEMBL20366867 | 0.78 | KMT2A (0.68) | PIN1TDP1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791299-B2 | Compounds for the inhibition of herpes viruses | UNIVERSITE LAVAL (CA) | 2014-07-29 | — | — | US | disclosed |
| US-20120157538-A1 | Compounds for the Inhibition of Herpes Viruses | UNIVERSITE LAVAL (CA) | 2012-06-21 | — | — | US | disclosed |
| WO-2010132992-A1 | COMPOUNDS FOR THE INHIBITION OF HERPESVIRUSES | UNIVERSITé LAVAL (CA) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157538-A1 | Compounds for the Inhibition of Herpes Viruses | NOS3, NOS1, DNA2 | NR4A1 403/4885NR4A2 376/4885NR4A3 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.